BE PIONEERING: The benefits of unlocking the value of diagnostic innovation in Alzheimer’s [Promoted content]

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to transform timely, accurate diagnosis for the benefit of patients and healthcare systems.